Biologics from Concept to Commercialisation

How Fluorochem Supports You

Biologics are a rapid growing class of therapeutics, taking an ever-larger share of the pharmaceutical market. Increasingly innovative and complex in design, production of biopharmaceuticals requires extensive interdisciplinary expertise. Our partners, ChemExpress have biologics production capabilities to match their small molecule offerings, ensuring the reliable and compliant manufacturing of monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), peptide-drug conjugates and other complex biologics. As a leading CDMO they provide end-to-end support from cell line development to downstream purification and fill-finish services.

Purpose-Built for Efficient, Compliant Biologics Manufacturing

With state-of-the-art mammalian expression systems, ChemExpress’s purpose-built facilities are designed to meet stringent cGMP, FDA and EMA regulatory requirements. Experienced teams handling process development, scale-up and tech transfer, ensuring seamless transitions from preclinical to clinical and commercial production of these complex products. Advanced single-use bioreactors and automated purification systems enhance efficiency while minimizing contamination risks.

With a strong regulatory track record and a commitment to quality, working with Fluorochem & ChemExpress ensures safe and compliant products, while bringing therapies to the clinic faster.

Contact us below to discuss how we can help develop your biologics pipeline.